Get access to our best features

Biogen agrees to $900 mln drug kickback settlement, U.S. Justice Dept says

Summary by Ground News
US pharmaceutical company Biogen has reached a $900 million settlement with a whistleblower who accused the firm of having paid bribes to doctors to encourage them to prescribe its drugs against multiple sclerosis. The whistleblower behind the report, Michael Bawduniak, will receive about $250 million directly, according to a statement released Monday by the US Justice Department.
2 months ago·Washington, United States

News Articles

More Filters
All
Left
Center
Right

US Pharma Co Biogen Accused of Bribing Doctors for Pushing Drug, Settle for $900mn with Whistleblower

US pharmaceutical company Biogen has reached a $900 million settlement with a whistleblower who accused the firm of having paid bribes to doctors to encourage them to prescribe its drugs against multiple sclerosis.

2 months ago·India
Read Full Article

Biogen agrees to $900 mln drug kickback settlement, U.S. Justice Dept says

WASHINGTON - The U.S. Justice Department said on Monday that Biogen Inc had agreed to pay $900 million to resolve allegations it paid doctors kickbacks to prescribe multiple sclerosis drugs, leading to the submission of false Medicare and Medicaid claims. (Reporting by Eric Beech and Rami Ayyub; Editing by Chris Reese)

2 months ago·United Kingdom
Read Full Article

Biogen pays $900M to settle doctor kickback allegations

BOSTON (AP) — Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors to persuade them to prescribe its multiple

2 months ago·United States
Read Full Article

Biogen pays $900M to settle doctor kickback allegations

Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors in the form of speakers and consulting fees to persuade them to prescribe its multiple sclerosis drugs

2 months ago·United States
Read Full Article

Pharmaceutical company Biogen agrees to pay $900 million to settle kickback claims

Pharmaceutical company Biogen Inc. has agreed to pay $900 million to settle allegations that it paid kickbacks to doctors to recommend its multiple sclerosis drugs, causing false submission claims to Medicare and Medicaid.

2 months ago·Washington, United States
Read Full Article

Biogen Agrees to Pay $900 Million to Settle Lawsuit Over Kickbacks

The company was accused of illegally paying doctors to prescribe its drugs over those of its rivals.

2 months ago·New York, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

37% of the sources are Center, 37% of the sources lean Right
Associated Press News
abc News
New York Times
Bloomberg
Boston.com
Reuters
CNBC
KRDO
UPI
WCVB
Chicago Tribune
+2
News18 India
Washington Times
National Post
MY Northwest
Boston Herald
The Epoch Times
The Blaze
L 26%
C 37%
R 37%
See less detail